SUTRO BIOPHARMA INC (STRO) Forecast, Price Target & Analyst Ratings

NASDAQ:STRO • US8693672011

Current stock price

36.62 USD
+1.23 (+3.48%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SUTRO BIOPHARMA INC (STRO).

Forecast Snapshot

Consensus Price Target

Price Target
$30.60
-16.44% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$3.85
Revenue Estimate
8.249M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.75%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$30.60
Upside
-16.44%
From current price of $36.62 to mean target of $30.60, Based on 16 analyst forecasts
Low
$8.08
Median
$28.56
High
$57.75

Price Target Revisions

1 Month
-7.69%
3 Months
-11.39%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for STRO. The average price target is 30.6 USD. This implies a price decrease of -16.44% is expected in the next year compared to the current price of 36.62.
The average price target has been revised downward by 11.39% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

STRO Current Analyst RatingSTRO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

STRO Historical Analyst RatingsSTRO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
78.75%
STRO was analyzed by 16 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about STRO.
In the previous month the buy percentage consensus was at a similar level.
STRO was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-30MizuhoInitiate Outperform
2026-04-23CitizensMaintains Market Outperform -> Market Outperform
2026-04-17CitizensMaintains Market Outperform -> Market Outperform
2026-04-07Leerink PartnersInitiate Outperform
2026-03-25Deutsche BankMaintains Buy -> Buy
2026-03-24Wells FargoUpgrade Equal-Weight -> Overweight
2026-03-24HC Wainwright & Co.Upgrade Neutral -> Buy
2026-01-20CitizensUpgrade Market Perform -> Market Outperform
2025-12-22HC Wainwright & Co.Maintains Neutral -> Neutral
2025-08-12Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-06-16Piper SandlerUpgrade Neutral -> Overweight
2025-05-19B of A SecuritiesMaintains Underperform -> Underperform
2025-04-29HC Wainwright & Co.Reiterate Neutral -> Neutral
2025-03-17HC Wainwright & Co.Downgrade Buy -> Neutral
2025-03-14Citizens Capital MarketsDowngrade Market Outperform -> Market Perform
2025-03-14WedbushDowngrade Outperform -> Neutral
2025-03-14B of A SecuritiesDowngrade Buy -> Underperform
2024-12-11JMP SecuritiesReiterate Market Outperform -> Market Outperform
2024-12-11Wells FargoMaintains Equal-Weight -> Equal-Weight
2024-11-18HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-11Piper SandlerReiterate Overweight -> Overweight
2024-10-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-16JMP SecuritiesReiterate Market Outperform -> Market Outperform
2024-09-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-16Truist SecuritiesMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$3.85
Revenue Estimate
8.249M
Revenue Q2Q
-52.59%
EPS Q2Q
57.64%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
-23.97%
Revenue (3 Months)
-23.97%
EPS (1 Month)
58.86%
EPS (3 Months)
60.86%

Next Earnings Summary

STRO is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -3.85 USD and the consensus revenue estimate is 8.25M USD.
The next earnings revenue estimate has been revised downward by 23.97% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
STRO revenue by date.STRO revenue by date.
153.731M
126.84%		62.043M
-59.64%		102.484M
65.18%		35.078M
-65.77%		32.271M
-8.00%		26.775M
-17.03%		34.88M
30.27%		70.289M
101.52%		119.35M
69.80%		171.41M
43.62%		183.94M
7.31%
EBITDA
YoY % growth
STRO ebitda by date.STRO ebitda by date.
-82.462M
33.09%		-231.235M
-180.41%		-97.628M
57.78%		-126.393M
-29.46%		-135.482M
-7.19%		-144.534M
-6.68%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
STRO ebit by date.STRO ebit by date.
-89.278M
30.76%		-238.453M
-167.09%		-104.952M
55.99%		-119.511M
-13.87%		-97.827M
18.14%		-97.054M
0.79%		-144.732M
-49.13%		-127.068M
12.20%		-55.867M
56.03%		-4.849M
91.32%		29.615M
710.71%
Operating Margin
STRO operating margin by date.STRO operating margin by date.
-58.07%-384.34%-102.41%-340.70%-303.14%-362.48%-414.94%-180.78%-46.81%-2.83%16.10%
EPS
YoY % growth
STRO eps by date.STRO eps by date.
-17.80
27.05%		-30.20
-69.66%		-22.49
25.53%		-8.57
61.91%		-8.96
-4.57%		-13.77
-53.68%		-1.73
87.40%		-1.73-1.84
-5.88%		-1.94
-5.56%		-1.94

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-3.85
57.64%		-3.24
-131.10%		-2.91
56.55%		-2.60
50.93%		-2.34
39.24%		-2.27
29.78%		-2.25
22.76%		-2.01
22.40%
Revenue
Q2Q % growth		8.249M
-52.59%		9.31M
-85.39%		7.628M
-21.30%		7.405M
-36.42%		2.04M
-75.27%		N/AN/AN/A
EBITDA
Q2Q % growth		-36.786M
19.28%		-25.648M
-235.87%		-30.641M
7.71%		-35.047M
-33.09%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-36.172M
23.80%		-32.158M
-313.29%		-30.635M
21.25%		-29.328M
12.86%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

STRO Yearly Revenue VS EstimatesSTRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M
STRO Yearly EPS VS EstimatesSTRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -10 -20 -30 -40 -50

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
11.55%
EPS Next 5 Year
13.97%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-35.80%
Revenue Next 5 Year
-7.03%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
2.49%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SUTRO BIOPHARMA INC / STRO Forecast FAQ

What is the average price target for SUTRO BIOPHARMA INC (STRO) stock?

16 analysts have analysed STRO and the average price target is 30.6 USD. This implies a price decrease of -16.44% is expected in the next year compared to the current price of 36.62.

Can you provide the upcoming earnings date for SUTRO BIOPHARMA INC?

SUTRO BIOPHARMA INC (STRO) will report earnings on 2026-05-06.

What are the consensus estimates for STRO stock next earnings?

The consensus EPS estimate for the next earnings of SUTRO BIOPHARMA INC (STRO) is -3.85 USD and the consensus revenue estimate is 8.25M USD.

What is the expected long term growth rate for SUTRO BIOPHARMA INC (STRO)?

The expected long term growth rate for SUTRO BIOPHARMA INC (STRO) is -35.8%.